Unexplained weight loss, defined as the unintentional loss of 5% or more of body weight within a six-month period, is a symptom that can be indicative of a variety of underlying medical conditions. This article aims to provide a systematic approach to the evaluation and management of patients presenting with this symptom.
The first step in the evaluation of unexplained weight loss should always be a thorough history and physical examination. It is crucial to rule out obvious causes such as changes in diet, physical activity, or medication use. If no clear cause is identified, further investigations should be guided by the patient's age, associated symptoms, and risk factors for specific diseases.
Endocrine disorders, malignancies, and gastrointestinal diseases are among the most common causes of unexplained weight loss. Other potential causes include psychiatric conditions, chronic infections, and malabsorption syndromes. Each of these categories should be systematically considered and investigated as appropriate.
Initial laboratory testing should include a complete blood count, metabolic panel, thyroid function tests, and inflammatory markers. Imaging studies and endoscopy may be indicated based on specific symptoms or risk factors. If these investigations do not reveal a cause, consider referral to a specialist for further evaluation.
Management of unexplained weight loss should be directed towards the underlying cause, if identified. In cases where no cause is found, symptomatic treatment and regular follow-up are recommended. Nutritional support may also be beneficial.
In conclusion, unexplained weight loss is a challenging symptom that requires a comprehensive and systematic approach. By considering a broad differential diagnosis and using a stepwise approach to investigation, physicians can effectively diagnose and manage this condition.
1.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
2.
Mezigdomide Combinations Show Promise in Multiple Myeloma
3.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
4.
Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.
5.
Oleanolic acid from grapes may increase chemotherapy effectiveness
1.
Advanced Approaches in Oncology and Patient Outcomes
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
Emerging Advances in Hematology and Quality Improvement
4.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
5.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
3.
Navigating the Complexities of Ph Negative ALL - Part XIV
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation